757 related articles for article (PubMed ID: 8625303)
21. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
22. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
Lieubeau-Teillet B; Rak J; Jothy S; Iliopoulos O; Kaelin W; Kerbel RS
Cancer Res; 1998 Nov; 58(21):4957-62. PubMed ID: 9810005
[TBL] [Abstract][Full Text] [Related]
23. Molecular targeting of VHL gene pathway in clear cell kidney cancer.
Linehan WM
J Urol; 2003 Aug; 170(2 Pt 1):593-4. PubMed ID: 12853837
[No Abstract] [Full Text] [Related]
24. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
Wykoff CC; Pugh CW; Maxwell PH; Harris AL; Ratcliffe PJ
Oncogene; 2000 Dec; 19(54):6297-305. PubMed ID: 11175344
[TBL] [Abstract][Full Text] [Related]
26. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein.
Na X; Duan HO; Messing EM; Schoen SR; Ryan CK; di Sant'Agnese PA; Golemis EA; Wu G
EMBO J; 2003 Aug; 22(16):4249-59. PubMed ID: 12912922
[TBL] [Abstract][Full Text] [Related]
27. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
28. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
30. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
Lee S; Neumann M; Stearman R; Stauber R; Pause A; Pavlakis GN; Klausner RD
Mol Cell Biol; 1999 Feb; 19(2):1486-97. PubMed ID: 9891082
[TBL] [Abstract][Full Text] [Related]
31. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
Kaelin WG
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
[TBL] [Abstract][Full Text] [Related]
32. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes.
Clifford SC; Czapla K; Richards FM; O'Donoghue DJ; Maher ER
Br J Cancer; 1998 May; 77(9):1420-8. PubMed ID: 9652757
[TBL] [Abstract][Full Text] [Related]
34. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos O; Levy AP; Jiang C; Kaelin WG; Goldberg MA
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10595-9. PubMed ID: 8855223
[TBL] [Abstract][Full Text] [Related]
35. Tumour suppression by the human von Hippel-Lindau gene product.
Iliopoulos O; Kibel A; Gray S; Kaelin WG
Nat Med; 1995 Aug; 1(8):822-6. PubMed ID: 7585187
[TBL] [Abstract][Full Text] [Related]
36. The von Hippel-Lindau tumor suppressor gene protects cells from UV-mediated apoptosis.
Schoenfeld AR; Parris T; Eisenberger A; Davidowitz EJ; De Leon M; Talasazan F; Devarajan P; Burk RD
Oncogene; 2000 Nov; 19(51):5851-7. PubMed ID: 11127815
[TBL] [Abstract][Full Text] [Related]
37. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells.
Masuda K; Ono M; Okamoto M; Morikawa W; Otsubo M; Migita T; Tsuneyoshi M; Okuda H; Shuin T; Naito S; Kuwano M
Int J Cancer; 2003 Jul; 105(6):803-10. PubMed ID: 12767066
[TBL] [Abstract][Full Text] [Related]
39. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.
Chan CC; Vortmeyer AO; Chew EY; Green WR; Matteson DM; Shen DF; Linehan WM; Lubensky IA; Zhuang Z
Arch Ophthalmol; 1999 May; 117(5):625-30. PubMed ID: 10326959
[TBL] [Abstract][Full Text] [Related]
40. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.
Iliopoulos O; Ohh M; Kaelin WG
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11661-6. PubMed ID: 9751722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
